(QRVO) Qorvo - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US74736K1016
Stock: Wireless Chips, Power Management, Sensors, RF
Total Rating 41
Risk 84
Buy Signal -0.46
| Risk 5d forecast | |
|---|---|
| Volatility | 42.6% |
| Relative Tail Risk | -15.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.38 |
| Alpha | -16.46 |
| Character TTM | |
|---|---|
| Beta | 1.754 |
| Beta Downside | 1.707 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.68% |
| CAGR/Max DD | -0.11 |
EPS (Earnings per Share)
Revenue
Description: QRVO Qorvo March 04, 2026
Qorvo, Inc. (QRVO) develops and sells wireless, wired, and power technologies. The company operates globally, with significant presence in Asia.
Qorvos business is divided into three segments. The High Performance Analog (HPA) segment focuses on radio frequency (RF) and power management for defense and 5G/6G infrastructure. Infrastructure development is a capital-intensive area for semiconductor companies.
The Connectivity and Sensors Group (CSG) provides solutions for smart homes, industrial automation, and automotive applications, utilizing technologies like UWB and Wi-Fi. The Internet of Things (IoT) market is a key growth driver for this segment.
The Advanced Cellular Group (ACG) supplies cellular RF solutions for mobile devices such as smartphones and wearables. Qorvo also offers foundry services for defense clients.
Qorvo distributes its products directly to manufacturers and through sales networks. To understand Qorvos detailed financial performance and market position, further research on platforms like ValueRay would be beneficial.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 340.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 1.55 > 1.0 |
| NWC/Revenue: 48.33% < 20% (prev 34.01%; Δ 14.32% < -1%) |
| CFO/TA 0.12 > 3% & CFO 731.5m > Net Income 340.6m |
| Net Debt (230.7m) to EBITDA (733.8m): 0.31 < 3 |
| Current Ratio: 3.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (93.8m) vs 12m ago -1.33% < -2% |
| Gross Margin: 44.38% > 18% (prev 0.41%; Δ 4397 % > 0.5%) |
| Asset Turnover: 61.68% > 50% (prev 63.57%; Δ -1.89% > 0%) |
| Interest Coverage Ratio: 6.20 > 6 (EBITDA TTM 733.8m / Interest Expense TTM 75.3m) |
Altman Z'' 4.14
| A: 0.29 (Total Current Assets 2.48b - Total Current Liabilities 675.7m) / Total Assets 6.16b |
| B: 0.04 (Retained Earnings 226.7m / Total Assets 6.16b) |
| C: 0.08 (EBIT TTM 467.1m / Avg Total Assets 6.06b) |
| D: 1.50 (Book Value of Equity 3.70b / Total Liabilities 2.47b) |
| Altman-Z'' Score: 4.14 = AA |
Beneish M -3.05
| DSRI: 1.20 (Receivables 520.1m/438.7m, Revenue 3.74b/3.79b) |
| GMI: 0.92 (GM 44.38% / 40.92%) |
| AQI: 0.93 (AQ_t 0.47 / AQ_t-1 0.51) |
| SGI: 0.99 (Revenue 3.74b / 3.79b) |
| TATA: -0.06 (NI 340.6m - CFO 731.5m) / TA 6.16b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of QRVO shares?
As of March 07, 2026, the stock is trading at USD 79.41 with a total of 1,372,199 shares traded.
Over the past week, the price has changed by -3.70%, over one month by -4.00%, over three months by -11.73% and over the past year by +11.62%.
Over the past week, the price has changed by -3.70%, over one month by -4.00%, over three months by -11.73% and over the past year by +11.62%.
Is QRVO a buy, sell or hold?
Qorvo has received a consensus analysts rating of 3.27.
Therefor, it is recommend to hold QRVO.
- StrongBuy: 4
- Buy: 3
- Hold: 16
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the QRVO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 88.4 | 11.4% |
| Analysts Target Price | 88.4 | 11.4% |
QRVO Fundamental Data Overview March 05, 2026
P/E Trailing = 22.3884
P/E Forward = 12.2699
P/S = 2.0146
P/B = 2.0535
P/EG = 0.1939
Revenue TTM = 3.74b USD
EBIT TTM = 467.1m USD
EBITDA TTM = 733.8m USD
Long Term Debt = 1.55b USD (from longTermDebt, last quarter)
Short Term Debt = 16.6m USD (from shortTermDebt, last fiscal year)
Debt = 1.55b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 230.7m USD (from netDebt column, last quarter)
Enterprise Value = 7.76b USD (7.53b + Debt 1.55b - CCE 1.32b)
Interest Coverage Ratio = 6.20 (Ebit TTM 467.1m / Interest Expense TTM 75.3m)
EV/FCF = 13.05x (Enterprise Value 7.76b / FCF TTM 595.2m)
FCF Yield = 7.67% (FCF TTM 595.2m / Enterprise Value 7.76b)
FCF Margin = 15.92% (FCF TTM 595.2m / Revenue TTM 3.74b)
Net Margin = 9.11% (Net Income TTM 340.6m / Revenue TTM 3.74b)
Gross Margin = 44.38% ((Revenue TTM 3.74b - Cost of Revenue TTM 2.08b) / Revenue TTM)
Gross Margin QoQ = 46.75% (prev 46.96%)
Tobins Q-Ratio = 1.26 (Enterprise Value 7.76b / Total Assets 6.16b)
Interest Expense / Debt = 1.16% (Interest Expense 18.0m / Debt 1.55b)
Taxrate = 13.56% (25.7m / 189.8m)
NOPAT = 403.7m (EBIT 467.1m * (1 - 13.56%))
Current Ratio = 3.67 (Total Current Assets 2.48b / Total Current Liabilities 675.7m)
Debt / Equity = 0.42 (Debt 1.55b / totalStockholderEquity, last quarter 3.70b)
Debt / EBITDA = 0.31 (Net Debt 230.7m / EBITDA 733.8m)
Debt / FCF = 0.39 (Net Debt 230.7m / FCF TTM 595.2m)
Total Stockholder Equity = 3.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.62% (Net Income 340.6m / Total Assets 6.16b)
RoE = 9.71% (Net Income TTM 340.6m / Total Stockholder Equity 3.51b)
RoCE = 9.23% (EBIT 467.1m / Capital Employed (Equity 3.51b + L.T.Debt 1.55b))
RoIC = 7.98% (NOPAT 403.7m / Invested Capital 5.06b)
WACC = 10.41% (E(7.53b)/V(9.08b) * Re(12.34%) + D(1.55b)/V(9.08b) * Rd(1.16%) * (1-Tc(0.14)))
Discount Rate = 12.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.76%
[DCF] Terminal Value 66.20% ; FCFF base≈550.5m ; Y1≈461.4m ; Y5≈343.0m
[DCF] Fair Price = 44.22 (EV 4.33b - Net Debt 230.7m = Equity 4.10b / Shares 92.7m; r=10.41% [WACC]; 5y FCF grow -19.57% → 2.90% )
EPS Correlation: -6.08 | EPS CAGR: -9.23% | SUE: 2.36 | # QB: 5
Revenue Correlation: -0.44 | Revenue CAGR: -4.20% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.97 | Chg7d=+0.001 | Chg30d=+0.001 | Revisions Net=-11 | Analysts=16
EPS next Year (2027-03-31): EPS=6.75 | Chg7d=+0.003 | Chg30d=-0.005 | Revisions Net=-3 | Growth EPS=+3.2% | Growth Revenue=-5.6%
[Analyst] Revisions Ratio: -0.73 (2 Up / 13 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.9% (Discount Rate 12.3% - Earnings Yield 4.5%)
[Growth] Growth Spread = -17.6% (Analyst -9.7% - Implied 7.9%)
P/E Forward = 12.2699
P/S = 2.0146
P/B = 2.0535
P/EG = 0.1939
Revenue TTM = 3.74b USD
EBIT TTM = 467.1m USD
EBITDA TTM = 733.8m USD
Long Term Debt = 1.55b USD (from longTermDebt, last quarter)
Short Term Debt = 16.6m USD (from shortTermDebt, last fiscal year)
Debt = 1.55b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 230.7m USD (from netDebt column, last quarter)
Enterprise Value = 7.76b USD (7.53b + Debt 1.55b - CCE 1.32b)
Interest Coverage Ratio = 6.20 (Ebit TTM 467.1m / Interest Expense TTM 75.3m)
EV/FCF = 13.05x (Enterprise Value 7.76b / FCF TTM 595.2m)
FCF Yield = 7.67% (FCF TTM 595.2m / Enterprise Value 7.76b)
FCF Margin = 15.92% (FCF TTM 595.2m / Revenue TTM 3.74b)
Net Margin = 9.11% (Net Income TTM 340.6m / Revenue TTM 3.74b)
Gross Margin = 44.38% ((Revenue TTM 3.74b - Cost of Revenue TTM 2.08b) / Revenue TTM)
Gross Margin QoQ = 46.75% (prev 46.96%)
Tobins Q-Ratio = 1.26 (Enterprise Value 7.76b / Total Assets 6.16b)
Interest Expense / Debt = 1.16% (Interest Expense 18.0m / Debt 1.55b)
Taxrate = 13.56% (25.7m / 189.8m)
NOPAT = 403.7m (EBIT 467.1m * (1 - 13.56%))
Current Ratio = 3.67 (Total Current Assets 2.48b / Total Current Liabilities 675.7m)
Debt / Equity = 0.42 (Debt 1.55b / totalStockholderEquity, last quarter 3.70b)
Debt / EBITDA = 0.31 (Net Debt 230.7m / EBITDA 733.8m)
Debt / FCF = 0.39 (Net Debt 230.7m / FCF TTM 595.2m)
Total Stockholder Equity = 3.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.62% (Net Income 340.6m / Total Assets 6.16b)
RoE = 9.71% (Net Income TTM 340.6m / Total Stockholder Equity 3.51b)
RoCE = 9.23% (EBIT 467.1m / Capital Employed (Equity 3.51b + L.T.Debt 1.55b))
RoIC = 7.98% (NOPAT 403.7m / Invested Capital 5.06b)
WACC = 10.41% (E(7.53b)/V(9.08b) * Re(12.34%) + D(1.55b)/V(9.08b) * Rd(1.16%) * (1-Tc(0.14)))
Discount Rate = 12.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.76%
[DCF] Terminal Value 66.20% ; FCFF base≈550.5m ; Y1≈461.4m ; Y5≈343.0m
[DCF] Fair Price = 44.22 (EV 4.33b - Net Debt 230.7m = Equity 4.10b / Shares 92.7m; r=10.41% [WACC]; 5y FCF grow -19.57% → 2.90% )
EPS Correlation: -6.08 | EPS CAGR: -9.23% | SUE: 2.36 | # QB: 5
Revenue Correlation: -0.44 | Revenue CAGR: -4.20% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.97 | Chg7d=+0.001 | Chg30d=+0.001 | Revisions Net=-11 | Analysts=16
EPS next Year (2027-03-31): EPS=6.75 | Chg7d=+0.003 | Chg30d=-0.005 | Revisions Net=-3 | Growth EPS=+3.2% | Growth Revenue=-5.6%
[Analyst] Revisions Ratio: -0.73 (2 Up / 13 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.9% (Discount Rate 12.3% - Earnings Yield 4.5%)
[Growth] Growth Spread = -17.6% (Analyst -9.7% - Implied 7.9%)